Serveur d'exploration Covid et maladies cardiovasculaires

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.

Identifieur interne : 000289 ( Main/Exploration ); précédent : 000288; suivant : 000290

Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.

Auteurs : Jessica Ferguson ; Joelle I. Rosser ; Orlando Quintero ; Jake Scott ; Aruna Subramanian ; Mohammad Gumma ; Angela Rogers ; Shanthi Kappagoda

Source :

RBID : pubmed:32407284

Descripteurs français

English descriptors

Abstract

Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.

DOI: 10.3201/eid2608.201776
PubMed: 32407284


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.</title>
<author>
<name sortKey="Ferguson, Jessica" sort="Ferguson, Jessica" uniqKey="Ferguson J" first="Jessica" last="Ferguson">Jessica Ferguson</name>
</author>
<author>
<name sortKey="Rosser, Joelle I" sort="Rosser, Joelle I" uniqKey="Rosser J" first="Joelle I" last="Rosser">Joelle I. Rosser</name>
</author>
<author>
<name sortKey="Quintero, Orlando" sort="Quintero, Orlando" uniqKey="Quintero O" first="Orlando" last="Quintero">Orlando Quintero</name>
</author>
<author>
<name sortKey="Scott, Jake" sort="Scott, Jake" uniqKey="Scott J" first="Jake" last="Scott">Jake Scott</name>
</author>
<author>
<name sortKey="Subramanian, Aruna" sort="Subramanian, Aruna" uniqKey="Subramanian A" first="Aruna" last="Subramanian">Aruna Subramanian</name>
</author>
<author>
<name sortKey="Gumma, Mohammad" sort="Gumma, Mohammad" uniqKey="Gumma M" first="Mohammad" last="Gumma">Mohammad Gumma</name>
</author>
<author>
<name sortKey="Rogers, Angela" sort="Rogers, Angela" uniqKey="Rogers A" first="Angela" last="Rogers">Angela Rogers</name>
</author>
<author>
<name sortKey="Kappagoda, Shanthi" sort="Kappagoda, Shanthi" uniqKey="Kappagoda S" first="Shanthi" last="Kappagoda">Shanthi Kappagoda</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32407284</idno>
<idno type="pmid">32407284</idno>
<idno type="doi">10.3201/eid2608.201776</idno>
<idno type="wicri:Area/Main/Corpus">000281</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000281</idno>
<idno type="wicri:Area/Main/Curation">000281</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000281</idno>
<idno type="wicri:Area/Main/Exploration">000281</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.</title>
<author>
<name sortKey="Ferguson, Jessica" sort="Ferguson, Jessica" uniqKey="Ferguson J" first="Jessica" last="Ferguson">Jessica Ferguson</name>
</author>
<author>
<name sortKey="Rosser, Joelle I" sort="Rosser, Joelle I" uniqKey="Rosser J" first="Joelle I" last="Rosser">Joelle I. Rosser</name>
</author>
<author>
<name sortKey="Quintero, Orlando" sort="Quintero, Orlando" uniqKey="Quintero O" first="Orlando" last="Quintero">Orlando Quintero</name>
</author>
<author>
<name sortKey="Scott, Jake" sort="Scott, Jake" uniqKey="Scott J" first="Jake" last="Scott">Jake Scott</name>
</author>
<author>
<name sortKey="Subramanian, Aruna" sort="Subramanian, Aruna" uniqKey="Subramanian A" first="Aruna" last="Subramanian">Aruna Subramanian</name>
</author>
<author>
<name sortKey="Gumma, Mohammad" sort="Gumma, Mohammad" uniqKey="Gumma M" first="Mohammad" last="Gumma">Mohammad Gumma</name>
</author>
<author>
<name sortKey="Rogers, Angela" sort="Rogers, Angela" uniqKey="Rogers A" first="Angela" last="Rogers">Angela Rogers</name>
</author>
<author>
<name sortKey="Kappagoda, Shanthi" sort="Kappagoda, Shanthi" uniqKey="Kappagoda S" first="Shanthi" last="Kappagoda">Shanthi Kappagoda</name>
</author>
</analytic>
<series>
<title level="j">Emerging infectious diseases</title>
<idno type="eISSN">1080-6059</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Asthma (epidemiology)</term>
<term>Asthma (physiopathology)</term>
<term>Azithromycin (therapeutic use)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>California (epidemiology)</term>
<term>Clinical Laboratory Techniques (methods)</term>
<term>Comorbidity (MeSH)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Diabetes Mellitus (epidemiology)</term>
<term>Diabetes Mellitus (physiopathology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hyperlipidemias (epidemiology)</term>
<term>Hyperlipidemias (physiopathology)</term>
<term>Hypertension (epidemiology)</term>
<term>Hypertension (physiopathology)</term>
<term>Intensive Care Units (MeSH)</term>
<term>Length of Stay (MeSH)</term>
<term>Male (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pulmonary Disease, Chronic Obstructive (epidemiology)</term>
<term>Pulmonary Disease, Chronic Obstructive (physiopathology)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Survival Analysis (MeSH)</term>
<term>Tomography, X-Ray Computed (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>AMP (analogues et dérivés)</term>
<term>AMP (usage thérapeutique)</term>
<term>Alanine (analogues et dérivés)</term>
<term>Alanine (usage thérapeutique)</term>
<term>Analyse de survie (MeSH)</term>
<term>Asthme (physiopathologie)</term>
<term>Asthme (épidémiologie)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Betacoronavirus (pathogénicité)</term>
<term>Broncho-pneumopathie chronique obstructive (physiopathologie)</term>
<term>Broncho-pneumopathie chronique obstructive (épidémiologie)</term>
<term>Californie (épidémiologie)</term>
<term>Comorbidité (MeSH)</term>
<term>Diabète (physiopathologie)</term>
<term>Diabète (épidémiologie)</term>
<term>Durée du séjour (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hyperlipidémies (physiopathologie)</term>
<term>Hyperlipidémies (épidémiologie)</term>
<term>Hypertension artérielle (physiopathologie)</term>
<term>Hypertension artérielle (épidémiologie)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Infections à coronavirus (mortalité)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>RT-PCR (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Techniques de laboratoire clinique (méthodes)</term>
<term>Tomodensitométrie (MeSH)</term>
<term>Unités de soins intensifs (MeSH)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Azithromycin</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>California</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>AMP</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Asthma</term>
<term>Coronavirus Infections</term>
<term>Diabetes Mellitus</term>
<term>Hyperlipidemias</term>
<term>Hypertension</term>
<term>Pneumonia, Viral</term>
<term>Pulmonary Disease, Chronic Obstructive</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Clinical Laboratory Techniques</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Techniques de laboratoire clinique</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Asthme</term>
<term>Broncho-pneumopathie chronique obstructive</term>
<term>Diabète</term>
<term>Hyperlipidémies</term>
<term>Hypertension artérielle</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Asthma</term>
<term>Diabetes Mellitus</term>
<term>Hyperlipidemias</term>
<term>Hypertension</term>
<term>Pulmonary Disease, Chronic Obstructive</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>AMP</term>
<term>Alanine</term>
<term>Azithromycine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Asthme</term>
<term>Broncho-pneumopathie chronique obstructive</term>
<term>Californie</term>
<term>Diabète</term>
<term>Hyperlipidémies</term>
<term>Hypertension artérielle</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Comorbidity</term>
<term>Female</term>
<term>Humans</term>
<term>Intensive Care Units</term>
<term>Length of Stay</term>
<term>Male</term>
<term>Pandemics</term>
<term>Retrospective Studies</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Severity of Illness Index</term>
<term>Survival Analysis</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Analyse de survie</term>
<term>Comorbidité</term>
<term>Durée du séjour</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>RT-PCR</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tomodensitométrie</term>
<term>Unités de soins intensifs</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32407284</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1080-6059</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>26</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Emerging infectious diseases</Title>
<ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.</ArticleTitle>
<Pagination>
<MedlinePgn>1679-1685</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2608.201776</ELocationID>
<Abstract>
<AbstractText>Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ferguson</LastName>
<ForeName>Jessica</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosser</LastName>
<ForeName>Joelle I</ForeName>
<Initials>JI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quintero</LastName>
<ForeName>Orlando</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scott</LastName>
<ForeName>Jake</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Subramanian</LastName>
<ForeName>Aruna</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gumma</LastName>
<ForeName>Mohammad</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rogers</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kappagoda</LastName>
<ForeName>Shanthi</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>T32 AI052073</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>05</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Emerg Infect Dis</MedlineTA>
<NlmUniqueID>9508155</NlmUniqueID>
<ISSNLinking>1080-6040</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C000657964">COVID-19 diagnostic testing</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006949" MajorTopicYN="N">Hyperlipidemias</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">California</Keyword>
<Keyword MajorTopicYN="Y">Coronavirus diseases</Keyword>
<Keyword MajorTopicYN="Y">ICU</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="Y">United States</Keyword>
<Keyword MajorTopicYN="Y">coronavirus disease</Keyword>
<Keyword MajorTopicYN="Y">hospitalization</Keyword>
<Keyword MajorTopicYN="Y">mortality</Keyword>
<Keyword MajorTopicYN="Y">outcomes</Keyword>
<Keyword MajorTopicYN="Y">pneumonia</Keyword>
<Keyword MajorTopicYN="Y">respiratory diseases</Keyword>
<Keyword MajorTopicYN="Y">severe acute respiratory syndrome coronavirus 2</Keyword>
<Keyword MajorTopicYN="Y">viruses</Keyword>
<Keyword MajorTopicYN="Y">zoonoses</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32407284</ArticleId>
<ArticleId IdType="doi">10.3201/eid2608.201776</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Ferguson, Jessica" sort="Ferguson, Jessica" uniqKey="Ferguson J" first="Jessica" last="Ferguson">Jessica Ferguson</name>
<name sortKey="Gumma, Mohammad" sort="Gumma, Mohammad" uniqKey="Gumma M" first="Mohammad" last="Gumma">Mohammad Gumma</name>
<name sortKey="Kappagoda, Shanthi" sort="Kappagoda, Shanthi" uniqKey="Kappagoda S" first="Shanthi" last="Kappagoda">Shanthi Kappagoda</name>
<name sortKey="Quintero, Orlando" sort="Quintero, Orlando" uniqKey="Quintero O" first="Orlando" last="Quintero">Orlando Quintero</name>
<name sortKey="Rogers, Angela" sort="Rogers, Angela" uniqKey="Rogers A" first="Angela" last="Rogers">Angela Rogers</name>
<name sortKey="Rosser, Joelle I" sort="Rosser, Joelle I" uniqKey="Rosser J" first="Joelle I" last="Rosser">Joelle I. Rosser</name>
<name sortKey="Scott, Jake" sort="Scott, Jake" uniqKey="Scott J" first="Jake" last="Scott">Jake Scott</name>
<name sortKey="Subramanian, Aruna" sort="Subramanian, Aruna" uniqKey="Subramanian A" first="Aruna" last="Subramanian">Aruna Subramanian</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000289 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000289 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CardioCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32407284
   |texte=   Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32407284" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CardioCovidV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Aug 4 15:08:30 2020. Site generation: Wed Jan 27 11:23:02 2021